About BellRing Brands We’re proud to say that we know little to pretty much zilch about the protein shake industry. Well, ok, that was a little harsh but hopefully you get our point. Maybe it might be more appropriate to say that we just don’t know much about the protein shake industry but we’re nevertheless […]
Stock Analysis: BellRing Brands (NYSE: BRBR) Read More »
About TransDigm Group It is safe to say that war is usually an ugly, soul wrenching, unfortunate occurrence. Nevertheless, war also tends to mean business and many businesses stand to gain plenty from the occurrence or even the slightest of hints of an upcoming war or the presence of heightened volatility in certain regions of
Stock Analysis: TransDigm Group (NYSE: TDG) Read More »
About Procter & Gamble If you’re reading while inside your neighborhood Walmart, Dollar General or any other grocery store or relatively well scaled retail establishment for that matter, stop reading, look around and take a deep inward breath. If you smell just hard enough, you should have little to no difficulty locating the store’s assortment
Stock Analysis: Procter & Gamble (NYSE: PG) Read More »
About Camden Property Trust Camden properties are mighty popular down in the southern half of the United States, especially in the great state of Texas. Owning and operating 171 properties with a total of 58,433 units across the United States, Camden can be thought of as a rather extensive real estate development company and operator,
Stock Analysis: Camden Property Trust (NYSE: CPT) Read More »
About Verifone This stock analysis article is a bit different from what we’ve traditionally done in the past, although we’ve put together our fair share of theoretical acquisition analysis articles as well as hedge fund manager analysis articles. So it’s not completely out of left field. Contrary to one’s initial belief, Verifone is not some
Should Verifone Acquire Square? Read More »
About Regeneron Pharmaceuticals For whatever reason, pharmaceutical companies and their stocks have been the word on the street at MacroHint. Regeneron is by no means an exception. Aside from having a name that sounds like one of the lost members of the Transformer’s, at its core Regeneron is a serious disease company, essentially focused on
Stock Analysis: Regeneron Pharmaceuticals (NASDAQ: REGN) Read More »
About Verisign It is safe to say that if the internet goes down for more than two seconds, people will absolutely lose their minds. This goes to show that what Verisign does is akin to the core concept of insurance; you don’t miss it or think about it when things are going well but when
Stock Analysis: Verisign (NASDAQ: VRSN) Read More »
About Cedar Fair If you don’t like the carnival, that’s fair. Do you like what we did there? Well, if you didn’t it’s a good thing that Cedar Fair isn’t 100% what it sounds like. Although the company’s stock ticker symbol is an accurate portrayal of what you will likely be having while at one
Stock Analysis: Cedar Fair (NYSE: FUN) Read More »
About Churchill Downs We at MacroHint like to think, analyze, think some more, write and then edit. And then think again. We also don’t consider ourselves to be particularly attracted to or attached to material things. The same might not necessarily be true for those who like to fly down on their private planes, hop
Stock Analysis: Churchill Downs (NASDAQ: CHDN) Read More »
About Alnylam Pharmaceuticals Alnylam is your run of the mill biopharmaceutical company. It has certain products it specializes in that separate itself from the competition, as is the case from other pharmaceutical companies, small and large. According to TD Ameritrade’s platform, Alnylam primarily focuses on and is “developing therapeutics based on ribonucleic acid interference (RNAi),”
Stock Analysis: Alnylam Pharmaceuticals (NASDAQ: ALNY) Read More »